Inventor · disambiguated record
Daniel R. Goldberg
Also filed as: GOLDBERG DANIEL · GOLDBERG DANIEL R
30 granted patents·6 pending applications·767 citations·filing 2000–2021
97Inventor score
Files withBOEHRINGER INGELHEIM PHARMA18KAROS PHARMACEUTICALS INC5ROIVANT SCIENCES GMBH5ALTAVANT SCIENCES GMBH3KINETA IMMUNO ONCOLOGY LLC2
Top patents by PatentIndex Score
36 records- 0198US6770639B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Aug 3, 2004·205 cites·5 claims
- 0298US6506769B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Jan 14, 2003·240 cites·32 claims
- 0396US10946018B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2020·Granted Mar 16, 2021·6 cites·18 claims
- 0496US9199994B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2014·Granted Dec 1, 2015·31 cites·48 claims
- 0594US10660893B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2019·Granted May 26, 2020·6 cites·18 claims
- 0694US10045988B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2017·Granted Aug 14, 2018·11 cites·26 claims
- 0794US9750740B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·14 cites·26 claims
- 0893US9512122B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsKAROS PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·15 cites·100 claims
- 0992US10350208B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsROIVANT SCIENCES GMBH·Filed 2018·Granted Jul 16, 2019·7 cites·36 claims
- 1092US6689804B2Small molecules useful in the treatment of inflammatory diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 10, 2004·46 cites·5 claims
- 1190US6852717B2Compounds useful as anti-inflammatory agentsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 8, 2005·43 cites·6 claims
- 1289US11759462B2Spirocyclic compounds as tryptophan hydroxylase inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Sep 19, 2023·1 cites·24 claims
- 1389US6492408B1Small molecules useful in the treatment of inflammatory diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Dec 10, 2002·35 cites·11 claims
- 1487US6489328B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Dec 3, 2002·29 cites·21 claims
- 1581US7511042B2Triazole compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Mar 31, 2009·16 cites·15 claims
- 1681US7078419B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Granted Jul 18, 2006·15 cites·16 claims
- 1780US7790712B2Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Sep 7, 2010·5 cites·5 claims
- 1879US7592332B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Sep 22, 2009·4 cites·8 claims
- 1979US6765009B21,4-Disubstituted benzo-fused compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jul 20, 2004·21 cites·24 claims
- 2076US10710948B2Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanoneROIVANT SCIENCES GMBH·Filed 2019·Granted Jul 14, 2020·0 cites·9 claims
- 2176US7335657B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Granted Feb 26, 2008·2 cites·16 claims
- 2271US7285545B2Cytokine inhibitorsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Oct 23, 2007·1 cites·14 claims
- 2370US7550494B2Small molecules useful in the treatment of inflammatory diseaseBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 23, 2009·5 cites·21 claims
- 2470US6844435B2Heterocyclic compounds useful as inhibitors of tyrosine kinasesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Jan 18, 2005·4 cites·9 claims
- 2569US8586748B22-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10ABEYWARDANE ASITHA·Filed 2009·Granted Nov 19, 2013·1 cites·5 claims
- 2669US8299123B2CCR10 antagonistsDEY KAKA·Filed 2008·Granted Oct 30, 2012·3 cites·8 claims
- 2764US11708365B2Processes for preparing TPH1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2021·Granted Jul 25, 2023·0 cites·25 claims
- 2863US2017204041A1Processes for preparing (r)-1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2960US9611201B2Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanoneKAROS PHARMACEUTICALS INC·Filed 2016·Granted Apr 4, 2017·0 cites·11 claims
- 3059US7115644B2Heterocyclic compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Oct 3, 2006·1 cites·16 claims
- 3158US2019263815A1Processes for preparing tph1 inhibitorsALTAVANT SCIENCES GMBH·Filed 2019·Application pending·0 cites
- 3256US2007275946A1Cytokine InhibitorsAUNGST RONALD A·Filed 2007·Application pending·0 cites
- 3351US2006276496A1Anti-Cytokine Heterocyclic CompoundsBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 3445US2020071316A1Activators of the retinoic acid inducible gene "rig-i" pathway and methods of use thereofKINETA IMMUNO ONCOLOGY LLC·Filed 2019·Application pending·0 cites
- 3545US2020055871A1Activators of the retinoic acid inducible gene "rig-i" pathway and methods of use thereofKINETA IMMUNO ONCOLOGY LLC·Filed 2019·Application pending·0 cites
- 3644US7550461B2Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jun 23, 2009·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Daniel R. Goldberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →